The Supreme People’s Court (SPC) of China has ruled in favor of Huawei in a jurisdictional dispute with MediaTek, confirming that the Guangzhou Intellectual Property Court (Guangzhou IP Court) has jurisdiction over two patent infringement lawsuits filed by Huawei in August 2024.I
On March 19, 2025, China’s State Council unveiled the Regulations on Handling Foreign-Related Intellectual Property Disputes (hereinafter referred to as the "Regulations"), which will take effect on May 1.
On January 6, 2025, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO), which is responsible for patent invalidation hearings, issued its final results of the IPR (Inter Partes Reviews) of BOE's challenge to two Samsung Display patents. The results
On 3 January, a wholly-owned subsidiary of Jinko Solar Co., Ltd. ("JinkoSolar"), filed a lawsuit against LONGi Green Energy Technology Co., Ltd. (“LONGi”), requesting the latter to immediately stop infringing the invention patents related to TOPCon technology and to compensa
Two recent announcements have put Delta-like ligand 3 (DLL3), a high-potential target, into the spotlight. Both Hengrui Pharma and Innovent's ADC innovative drugs were licensed out for more than US$1 billion. DLL3Antibody–drug conjugates or ADCs are a class of biopharmaceutical drugs design
